| 来源类型 | Working Paper |
| 规范类型 | 报告 |
| DOI | 10.3386/w23956 |
| 来源ID | Working Paper 23956 |
| A Dose of Managed Care: Controlling Drug Spending in Medicaid | |
| David Dranove; Christopher Ody; Amanda Starc | |
| 发表日期 | 2017-10-23 |
| 出版年 | 2017 |
| 语种 | 英语 |
| 摘要 | Effectively designed market mechanisms may reduce growth in health care spending. In this paper, we study the impact of privatizing the delivery of Medicaid drug benefits on drug spending. Exploiting granular data that allow us to examine drug utilization, we find that drug spending would fall by 22.4 percent if the drug benefit was fully administered by Medicaid Managed Care Organizations (MCOs), largely through lower point-of-sale prices and greater generic usage. The effects are driven by MCOs’ ability to design drug benefits and steer consumers toward lower cost drugs and pharmacies. MCOs do not appear to skimp on performance, either by reducing overall drug consumption as measured by prescriptions per enrollee or reducing utilization of drugs that offset other medical spending. |
| 主题 | Health, Education, and Welfare ; Health ; Industrial Organization ; Market Structure and Firm Performance |
| URL | https://www.nber.org/papers/w23956 |
| 来源智库 | National Bureau of Economic Research (United States) |
| 引用统计 | |
| 资源类型 | 智库出版物 |
| 条目标识符 | http://119.78.100.153/handle/2XGU8XDN/581629 |
| 推荐引用方式 GB/T 7714 | David Dranove,Christopher Ody,Amanda Starc. A Dose of Managed Care: Controlling Drug Spending in Medicaid. 2017. |
| 条目包含的文件 | ||||||
| 文件名称/大小 | 资源类型 | 版本类型 | 开放类型 | 使用许可 | ||
| w23956.pdf（1259KB） | 智库出版物 | 限制开放 | CC BY-NC-SA | 浏览 | ||
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
